NK-T CELL LYMPHOMA IMMUNOTHERAPY TREATMENTS ADVANCE

  • Korean biotechnology companies develop Immunotherapy treatments for rare blood cancers.

References

Yeom Hyun-a. 2025.07.15. Korean firms advance NK-T cell lymphoma treatments leveraging high EBV infection rates. CHOSUNBIZ. https://biz.chosun.com/en/en-science/2025/07/15/DQSEDE2LLBF4FBNIIPS3DV6W64

2 thoughts on “NK-T CELL LYMPHOMA IMMUNOTHERAPY TREATMENTS ADVANCE

Leave a Reply

Your email address will not be published. Required fields are marked *